Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of theta burst stimulation (TBS), alone and compared with repetitive transcranial magnetic stimulation (rTMS) and/or with sham TBS, for the management of treatment-resistant major depressive disorder (MDD) (unipolar treatment-…
Evidence Analysis
It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
- Does the technology improve health outcomes?
- Are there other benefits associated with the technology?
- What harms might be associated with the technology?
- Have patient selection criteria been established for the technology?
- For which patients might the technology provide a benefit?
- Health Technology Assessments
- Evidence Analysis Research Briefs
- Evolving Evidence Review
- Clinical Research Responses
Laser Interstitial Thermal Therapy for Treatment of Recurrent Metastatic Brain Neoplasms
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of laser interstitial thermal therapy (LITT), also known as stereotactic laser ablation (SLA), for the treatment of recurrent metastatic brain neoplasms.
Trabecular Bone Score to Predict Fracture Risk in Postmenopausal Patients
Focus of the Report: The focus of this Health Technology Assessment is evaluation of the effectiveness and safety of the trabecular bone score (TBS) as an adjunct to bone mineral density (BMD) measurement and/or other validated tools incorporating patient information for prediction of fracture risk and guidance of preventive treatment in post…
neoGEN-Series System (RST-Sanexas) for Treatment of Neuropathic Pain
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the neoGEN-Series system (RST-Sanexas) for the treatment of neuropathic pain for outcomes including pain, function, quality of life, and safety.
Cooled or Pulsed Radiofrequency for Chronic Low Back Pain Arising From the Sacroiliac Joint
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of cooled radiofrequency ablation (CRFA) and pulsed radiofrequency (PRF) for the treatment of chronic low back pain (CLBP) that originates from the sacroiliac joint (SIJ).
Tec…
The iovera° (Pacira Biosciences Inc.) System for Knee Osteoarthritis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cryoneurolysis using the iovera° system for outpatient management of nonsurgical knee pain due to osteoarthritis.
ReCell Autologous Skin Cell Suspension (Avita Medical) Combined with Meshed Autograft for Treatment of Acute Thermal Full-Thickness or Mixed-Thickness Burns
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cell suspensions prepared with the ReCell Autologous Cell Harvesting Device (Avita Medical) combined with meshed autograft for the treatment of acute full-thickness and mixed-thickness thermal burns compared with standard ca…
Mako Robotic-Arm (Stryker Corp.) Assisted Total Knee Arthroplasty
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of the Mako Robotic-Arm assisted total knee arthroplasty (RATKA) system (Stryker) compared with manual total knee arthroplasty (TKA) for the treatment of knee osteoarthritis (KOA).
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the eXciteOSA device for the treatment of primary snoring and mild obstructive sleep apnea (OSA). This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of PuraPly AM for wound healing in adult patients.eXciteOSA Device (Signifier Medical Technologies LLC) for Treatment of Snoring in Patients With Primary Snoring or Mild Obstructive Sleep Apnea
PuraPly AM Antimicrobial Wound Matrix (Organogenesis) for Treatment of Wounds